|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.94 CNY | -0.27% |
|
-0.46% | -1.22% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Preparations | - | 298M | 235M | 187M | 55.36M | |||
Active Pharmaceutical Ingredient (api) | - | - | - | 10.32M | 49.74M | |||
Intermediate | - | 103M | 99.61M | 38M | 38.96M | |||
Others | 64.26M | - | - | 5.51M | 10.11M | |||
Gross Profit | - | - | - | - | - | |||
Sodium Acetate Ringer's Injection | 465M | - | - | - | - | |||
Gross Profit | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
China | 530M | 401M | 334M | 241M | 154M | |||
Total Assets | 851M | 899M | 1.07B | 1.53B | 1.28B | |||
Interest Expense | -1.18M | -1.36M | -3.11M | -7.9M | -17.94M | |||
Income Tax Expense | 7.42M | 2.44M | 5.16M | -746K | 1.04M | |||
D&A | 14.8M | 15.69M | 18.7M | 29.26M | 52M | |||
CAPEX | -5.35M | -32.73M | -23.69M | -40.92M | -102M | |||
Net Income | 68.51M | 20.5M | 18.85M | -62.67M | -102M | |||
EBT | 73.28M | 21.02M | 22.25M | -85.77M | -131M | |||
Operating Income | 73.4M | 21.26M | 22.19M | -85.76M | -128M |
Select your edition
All financial news and data tailored to specific country editions
